LEGN · Legend Biotech Corp · Documents
Market Cap
$3.62B
Shares
194.49M
Volume · Oct 22
1.2M
Avg daily vol (3M)
2.3M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2024-11-12 | 2024-09-30 | |
| 6-K | — | 2024-11-05 | 2024-11-04 | |
| 6-K | — | 2024-10-22 | — | |
| 6-K | — | 2024-10-21 | — | |
| 6-K | — | 2024-10-15 | — | |
| 6-K | — | 2024-09-27 | — | |
| 6-K | — | 2024-09-20 | — | |
| 6-K | — | 2024-08-27 | — | |
| 6-K | — | 2024-08-09 | 2024-06-30 | |
| 6-K | — | 2024-08-08 | — | |
| 6-K | — | 2024-07-26 | — | |
| 6-K | — | 2024-07-17 | — | |
| 6-K | — | 2024-07-02 | — | |
| 6-K | — | 2024-06-03 | — | |
| 6-K | — | 2024-05-23 | — | |
| 6-K | — | 2024-05-13 | 2024-03-31 | |
| 6-K | — | 2024-04-22 | — | |
| 6-K | — | 2024-04-16 | — | |
| 6-K | — | 2024-04-08 | 2024-04-05 | |
| 6-K | — | 2024-03-29 | — | |
| 20-F | — | 2024-03-19 | 2023-12-31 | |
| F-3ASR | — | 2024-03-19 | — | |
| 6-K | — | 2024-03-15 | — | |
| 6-K | — | 2024-03-13 | — | |
| 6-K | — | 2024-03-11 | 2023-12-31 | |
| 6-K | — | 2024-02-23 | 2024-02-22 | |
| 6-K | — | 2024-01-23 | — | |
| 6-K | — | 2024-01-23 | — | |
| 6-K | — | 2024-01-09 | — | |
| 6-K | — | 2023-12-21 | — | |
| 6-K | — | 2023-12-21 | — | |
| 6-K | — | 2023-12-12 | 2023-12-11 | |
| 6-K | — | 2023-11-20 | 2023-09-30 | |
| 6-K | — | 2023-11-13 | — | |
| 6-K | — | 2023-10-17 | — | |
| 6-K | — | 2023-09-25 | — | |
| 6-K | — | 2023-08-28 | — | |
| 6-K | — | 2023-08-21 | — | |
| 6-K | — | 2023-08-15 | 2023-06-30 | |
| 6-K | — | 2023-07-20 | — | |
| 6-K | — | 2023-06-06 | — | |
| 6-K | — | 2023-06-05 | — | |
| F-3ASR | — | 2023-05-26 | — | |
| 6-K | — | 2023-05-25 | — | |
| 6-K | — | 2023-05-18 | — | |
| 6-K | — | 2023-05-16 | — | |
| 6-K | — | 2023-05-12 | — | |
| 6-K | — | 2023-05-08 | 2023-05-05 | |
| 6-K | — | 2023-04-21 | — | |
| 6-K | — | 2023-04-19 | — |
Showing 51–100 of 207 filings
Key facts
CIK
1801198
CUSIP
52490G102
13F (30d)
14 filings
14 filers
Visit website
Investor relations